Galen announces the opening of the 2025 John Hinds Scholarship Award in partnership with the College of Paramedics
Galen, the privately owned pharmaceutical company, is now into its sixth year of sponsoring the John Hinds Scholarship Award in association with the College of Paramedics. The Scholarship is presented in memory of Dr John Hinds who is highly regar...
John Hinds Scholarship Award 2025
The John Hinds Scholarship Award is presented in memory of the inspirational Dr John Hinds, a man held in high regard by prehospital and emergency care workers. He selflessly gave a huge amount of his own time to further educate and support many p...
Galen launches three-year partnership with Ulster University to support new Paramedic Sciences Award
Galen, the privately-owned pharmaceutical sales and marketing company, and founding member of the Almac Group, has announced a three-year partnership with Ulster University to support a new award for the BSc Hons Paramedic Science programme.
Gale...
Galen supports Global Emergency Care Skills charity
Global Emergency Care Skills (GECS) is an Irish voluntary non-profit organisation that provides trauma skills training to doctors, nurses and clinical officers in African Hospitals.
Sepsis and trauma are two of the fastest-growing causes of morbi...
Galen announces exclusive licensing agreement with Italfarmaco for the distribution of Cariban® (doxylamine/pyridoxine) in Ireland for nausea and vomiting in pregnancy
CRAIGAVON, NORTHERN IRELAND – 30th July 2024. Galen Ltd announced today that it has entered into an exclusive licensing agreement with Italfarmaco for the prescription medicine Cariban® (doxylamine/pyridoxine) in Ireland, to alleviate the symptoms...
Pregnant women in Ireland can now access a fully reimbursed medicine for the treatment of Nausea and Vomiting in Pregnancy
Women who suffer with Nausea and Vomiting in Pregnancy (NVP) can now access the medicine doxylamine/pyridoxine through the Drugs Payment Scheme or Medical Card
NVP can affect up to 80% of expectant mothers but managing it adequately in its earl...
Galen launches new education support programme 'Galen's Learning Lab'
Supporting patients with inherited metabolic disorders accessing educational support
Galen, the privately-owned pharmaceutical sales and marketing company, is pleased to announce the launch of their new educational support programme, '...
POA Pharma announces expansion into Austria, deepening its inborn metabolic disease footprint in Europe
POA Pharma Scandinavia AB, a speciality pharmaceutical company with expertise across multiple therapeutic areas, has today announced the launch of PKU Easy Microtabs Plus in Austria.
This marks the latest milestone for POA Pharma, as it continues...
Galen announces Simon Fell as the winner of the Dr John Hinds Scholarship Award 2024
Galen, a privately owned pharmaceutical company, announced Simon Fell as the winner of the Dr John Hinds Scholarship Award for 2024, in association with the College of Paramedics and The ATACC Group.
Simon, a Clinical Service Improvement Lead for...
The Pharma Letter: Galen sticking to its principles as it embarks on ambitious future
Dr Dennise Broderick, Managing Director & President of Galen, in her recent interview with The Pharma Letter talks about staying true to her values, Galen sticking to its principles as it embarks on an ambitious future and inspi...
Almac Group signs power purchase agreement (PPA) with NTR for renewable energy
Almac will reduce carbon emissions from electricity at Craigavon headquarters by 95% through wind power purchase agreement.
Almac Group today announced a 15-year virtual power purchase agreement (VPPA) to source electricity generated by the newly...
Galen announces exclusive licensing agreement with Almeda Pharmaceuticals AG
Galen, the privately-owned pharmaceutical sales and marketing company, is pleased to announce a significant milestone in its global expansion strategy with the signing of an exclusive licensing deal with Almeda Pharmaceuticals AG.
The agreement p...
The Swallows Charity benefits from Galen’s £3,000 cheque donation
Last week, the Galen team had the incredible opportunity to attend the Head and Neck Cancer Conference in Torquay, where we learned and connected with patients and experts in the field. During the event, Galen's Commercial Director ...
Galen Announces Dr John Hinds Scholarship Award for 2024 in partnership with The College of Paramedics
Galen, the privately-owned pharmaceutical sales and marketing company is pleased to announce that applications are now open for the Dr John Hinds Scholarship Award 2024. This prestigious scholarship, now in its fifth year, is dedicated to supporti...
Dr. John Hinds Scholarship Award 2024
The John Hinds Scholarship Award is presented in memory of the late Dr John Hinds, a man held in high regard as an inspirational leader by Paramedics/EMTs and indeed anyone with an interest in prehospital care in both Northern Ireland and ...
Galen Medical Nutrition announces the release of latest innovation: PKU Easy Microtabs Plus
Galen, the privately-owned pharmaceutical sales and marketing company, has today announced the release of their latest innovative product, PKU Easy Microtabs Plus from their Medical Nutrition range, into the European market.
Designed specifically...
Galen honours Shane Fahy as the recipient of the Dr John Hinds Scholarship Award 2023
Galen, a privately owned pharmaceutical company, has named Shane Fahy as the winner of the Dr John Hinds Scholarship Award for 2023, in association with the College of Paramedics and The ATACC Group.
The scholarship is presented i...
POA Pharma announces expansion into Germany
POA Pharma Scandinavia AB, a speciality pharmaceutical company with expertise across multiple therapeutic areas, has today announced its expansion into Germany as POA Pharma GmbH.
POA Pharma, headquartered in Copenhagen with additional faci...
Galen and College of Paramedics call for entries for the Dr John Hinds Scholarship Award 2023
Galen, the privately-owned pharmaceutical sales and marketing company is pleased to announce that applications for the Dr John Hinds Scholarship Award 2023 are now open across Northern Ireland and the Republic of Ireland.
The scholarship, w...
Galen Medical Nutrition announces launch of TYR EASY Tablets in the UK
Galen the privately-owned pharmaceutical sales, and marketing company, has today announced the launch of their TYR EASY Tablets, the first solid-dose protein substitute option for tyrosinaemia, into the UK market.
Galen’s TYR EASY Tab...
Galen and The College of Paramedics award Barry Costello as Winner of the Dr John Hinds Scholarship Award 2022
Galen, in association with the College of Paramedics and The ATACC Group, is proud to name Barry Costello as the winner of the Dr John Hinds Scholarship Award 2022.
Barry was presented his award at a celebratory afternoon tea at the International...
Galen Announces Medical Nutrition Scholarship Award Winners for 2022
Galen is proud to announce the winners of the Galen Medical Nutrition Scholarship Award for 2022 as Stuart Noble from Merseyside, England and Kaisa Minnie Haugen from Stjørdal in Norway.
The scholarship was on offer to people with metabolic disor...
POA Pharma, enters the German market, securing exclusive in-licensing rights for Rapilose Oral Glucose Solution (OGS)
POA Pharma Scandinavia AB, a Galen Limited owned company, has announced its entry into the German market, securing an exclusive in-licensing agreement with Penlan Healthcare Limited for Rapilose OGS.
POA Pharma’s parent company, Galen Limited, a ...
Galen Medical Nutrition Announces Scholarship Award is open for applications
Supporting patients with metabolic disorders accessing further education
Galen, the privately-owned pharmaceutical sales and marketing company, has announced that the application process for their Medical Nutrition Scholarship Award is now open.
...
Galen expands product portfolio with GelX® Oral Spray
Galen, a global pharmaceutical company, and part of the Almac Group headquartered in Craigavon, has announced a new partnership with Sunstar Suisse S.A. to exclusively distribute and commercialise GelX® Oral Spray in the United Kingdom and Ireland...
Galen expands product portfolio with Provocholine® (methacholine chloride)
Galen, a global pharmaceutical company, and part of the Almac Group headquartered in Craigavon, has acquired the rights to Provocholine® 100 mg Powder for nebuliser solution (methacholine chloride), manufactured by Methapharm Specialty Pharmaceuti...
The College of Paramedics Opens Dr John Hinds Scholarship Call for Entries
Craigavon, N.I., Tuesday 1st Febraury 2022- The College of Paramedics, in association with Galen, the privately-owned pharmaceutical sales and marketing company is pleased to announce that applications for this year’s Dr John Hinds Scholarshi...
Nexus Patient Services Announces Distribution Agreement with Galen Medical Nutrition
October 15, 2021
Nexus Patient Services today announced an agreement with Galen US Inc. to become the sole distributor for Galen Medical Nutrition in the United States. This agreement allows Nexus to provide continued access to Galen’s high...
Galen Announces Medical Nutrition Scholarship Award Winners 2021
Ella Roberts (Wilshire, England) and Fergal Egan (Limerick, Ireland) named winners of the inaugural program
Craigavon, U.K. – 20 September 2021 - Galen, the privately-owned pharmaceutical sales and marketing company, is proud to announce the winn...
Galen Medical Nutrition Announces Scholarship Award
Supporting patients with metabolic disorders accessing further education
Craigavon, U.K. – 27 Jul 2021 - Galen, the privately-owned pharmaceutical sales and marketing company, is pleased to announce the inaugural Galen Medical Nutrition Scholarsh...
Dr John Hinds Scholarship Award Winner Announced
Craigavon, U.K. – 18 May 2021 - The College of Paramedics, in association with Galen, the privately owned pharmaceutical sales and marketing company, is proud to announce the winner of the Dr John Hinds Scholarship Award 2021: Edel Mullen of Natio...
NI Chamber in conversation with Dr Dennise Broderick - Managing Director, Galen
Dr Dennise Broderick, Managing Director & President of Galen, shares how combining a passion for science and love of business has shaped her extensive career and catapulted her to leadership roles with pharmaceutical companies across the globe...
The College of Paramedics Opens Dr John Hinds Scholarship Call for Entries
Craigavon, N.I., 25 January 2021 – The College of Paramedics, in association with Galen, the privately-owned pharmaceutical sales and marketing company is pleased to announce that applications for this year’s Dr John Hinds Scholarship Award will o...
Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19
Employee-driven initiative will benefit 33 health and welfare organisations local to Almac’s 11 global facilities
Craigavon, Northern Ireland - 02 September 2020 – Almac Group has today announced the organisation will donate £250,000 to 33 charit...
Announcing the Winner of the Dr John Hinds Scholarship Award 2020
Craigavon, U.K. – 16 Jun 2020 - Today, the College of Paramedics, in association with Galen, the privately owned pharmaceutical sales and marketing company, is proud to announce the winner of the Dr John Hinds Scholarship Award 2020: Orla Morrow o...
Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments
Inhaled analgesic can save average patient 71 minutes for some common injuries compared to traditional therapies
Craigavon, N.I., Tuesday 31 March 2020 - An inhaled analgesic recently introduced to the UK can save more than one hour per appropria...
Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK
Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK
Craigavon, N.I., 13 Feb 2020 – An innovative medical food (food for special medical purpose) for people living with t...
Galen Announces Completion of Multi-Million Pound POA Pharma Acquisition
Move adds substantial new therapeutic areas and territories to Galen’s reach
Craigavon, N.I., 8 Jan 2020 - Galen, the privately owned global pharmaceutical sales and marketing company, today announced the completion of a multi-million pound acqui...
Galen attends the Royal College of Emergency Medicine annual scientific meeting 2019
Galen were this year’s platinum sponsors at the Royal College of Emergency Medicine annual scientific meeting in The Sage, Gateshead.
The Galen Penthrox team spent three days with some of emergency medicine’s key opinion leaders in what was a tru...
NI Chamber Puts Dr Dennise Broderick under the Spotlight
Galen President and MD first keynote speaker in CEO Spotlight Series
Craigavon, N.I., 7 Oct 2019 - Dr. Dennise Broderick, President and Managing Director of global speciality pharmaceutical company, Galen, was the first member to participate in N...
Dr Dennise Broderick, President and Managing Director of Galen, explains her commitment to driving growth with a strong focus on the customer and the patient.
Driving growth through patient focus
Dr Dennise Broderick, President and Managing Director of Galen (a member of the Almac Group), explains her commitment to driving growth with a strong focus on the customer and the patient.
Article published i...
Galen Appoints Dr Dennise Broderick as Managing Director
15th January 2019 | Galen Ltd, the Northern Ireland based pharmaceutical company, is delighted to announce the appointment of Dr Dennise Broderick as its new Managing Director and President. She will report to Alan Armstrong, CEO and Chairman, Alm...
Galen expands further into US with significant acquisition
11th July 2013 | Galen Ltd, the Craigavon-based pharmaceutical company that is part of Almac Group, has reached a significant deal with a US company to acquire the rights to a leading medicinal product.
Galen US, Inc., a wholly owned subsidiary o...
Galen acquires Synera
11th July 2013 | SOUDERTON, PENNSYLVANIA
Galen, a Northern Ireland based pharmaceutical company, has acquired Synera® (lidocaine 70mg/tetracaine 70mg) topical patch from ZARS Pharma Inc., a wholly owned subsidiary of Nuvo Research Inc. Synera® is...
UK
Galen Limited
Seagoe Industrial Estate
Craigavon
BT63 5UA
United Kingdom
Telephone:+44 (0)28 3833 4974
Email:
Nordics
POA Pharma Scandinavia AB
Banevænget 13, 1.
3460 Birkerød
Denmark
Telephone: +45 3117 4300
Email:
Germany
POA Pharma GmbH
Langenbruchstraße 20A
D-45549 Sprockhövel
Germany
Telephone: +49 (0)2339 9113404
Email:
